BAYER PHARMA PATENTS FACING OPPOSITIONS
Top patents of BAYER PHARMA facing oppositions at the European Patent Office (EPO)
| Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
|---|---|---|---|---|---|
| EP3325013B2 | 19 Jul, 2023 | Stimulators And/Or Activators Of Soluble Guanylate Cyclase (Sgc) In Combination With An Inhibitor Of Neutral Endopeptidase (Nep Inhibitor) And/Or An Angiotensin Aii Antagonist And The Use Thereof | Jul, 2036 | 1 | |
| EP3611169B1 | 21 Jul, 2021 | New Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging | May, 2036 | 1 | |
| EP3303307B1 | 04 Sep, 2019 | New Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging | NA | 1 | |
| EP2532676B1 | 22 Mar, 2017 | Protease-Regulated Antibody | NA | 1 |